Xenetic Biosciences (NASDAQ:XBIO – Get Free Report) and Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, analyst recommendations and risk.
Analyst Ratings
This is a summary of current recommendations and price targets for Xenetic Biosciences and Nature’s Sunshine Products, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Xenetic Biosciences | 1 | 0 | 0 | 0 | 1.00 |
| Nature’s Sunshine Products | 0 | 0 | 3 | 0 | 3.00 |
Nature’s Sunshine Products has a consensus target price of $35.00, suggesting a potential upside of 59.60%. Given Nature’s Sunshine Products’ stronger consensus rating and higher probable upside, analysts plainly believe Nature’s Sunshine Products is more favorable than Xenetic Biosciences.
Insider & Institutional Ownership
Profitability
This table compares Xenetic Biosciences and Nature’s Sunshine Products’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Xenetic Biosciences | -70.03% | -39.28% | -33.47% |
| Nature’s Sunshine Products | 4.06% | 14.67% | 9.27% |
Volatility & Risk
Xenetic Biosciences has a beta of 2.2, indicating that its stock price is 120% more volatile than the S&P 500. Comparatively, Nature’s Sunshine Products has a beta of 0.95, indicating that its stock price is 5% less volatile than the S&P 500.
Valuation & Earnings
This table compares Xenetic Biosciences and Nature’s Sunshine Products”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Xenetic Biosciences | $2.98 million | 2.18 | -$2.68 million | ($1.20) | -2.37 |
| Nature’s Sunshine Products | $480.14 million | 0.80 | $19.52 million | $1.10 | 19.94 |
Nature’s Sunshine Products has higher revenue and earnings than Xenetic Biosciences. Xenetic Biosciences is trading at a lower price-to-earnings ratio than Nature’s Sunshine Products, indicating that it is currently the more affordable of the two stocks.
Summary
Nature’s Sunshine Products beats Xenetic Biosciences on 11 of the 14 factors compared between the two stocks.
About Xenetic Biosciences
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The Company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications.
About Nature’s Sunshine Products
Nature’s Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature’s Sunshine and Synergy WorldWide brands through a sales force of independent consultants. Nature’s Sunshine Products, Inc. was founded in 1972 and is headquartered in Lehi, Utah.
Receive News & Ratings for Xenetic Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xenetic Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
